Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB)

Price 171.00p on 01-03-2024 at 18:01:29
Change -1.00p -0.58%
Buy 170.80p
Sell 170.00p
Buy / Sell OXB Shares
Last Trade: Unknown 3,597.00 at 171.00p
Day's Volume: 170,115
Last Close: 171.00p
Open: 174.00p
Day's Range 167.60p - 174.00p
52wk Range: 164.40p - 575.00p
Market Capitalisation: £171m
VWAP: 169.87647p
Shares in Issue: 100m

Recent Trades History Oxford Biomedica (OXB)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 3,597 171.00p Currency Conversion
OTC Trade
18:01:11 - 01-Mar-24
Unknown* 431 170.071p Currency Conversion
OTC Trade
17:34:55 - 01-Mar-24
Unknown* 3,500 169.099p Currency Conversion
OTC Trade
17:31:41 - 01-Mar-24
Unknown* 600 170.709p Currency Conversion
OTC Trade
17:31:37 - 01-Mar-24
Unknown* 64 168.399p Currency Conversion
OTC Trade
17:19:43 - 01-Mar-24
Unknown* 120 171.00p Currency Conversion
OTC Trade
17:13:33 - 01-Mar-24
Unknown* 2,184 171.009p Currency Conversion
OTC Trade
16:55:57 - 01-Mar-24
Unknown* 316 169.234p Currency Conversion
OTC Trade
16:52:40 - 01-Mar-24
Unknown* 457 170.349p Currency Conversion
OTC Trade
16:39:47 - 01-Mar-24
Buy* 30,145 171.00p Suspected BUY Trade
16:35:28 - 01-Mar-24

Share Price History for Oxford Biomedica

Time period:
Date Open High Low Close Volume

Share News for Oxford Biomedica

EnSilica hires new chief financial officer from Oxford Biomedica

5th Feb 2024 11:34

(Alliance News) - EnSilica PLC on Monday said it has appointed a new chief financial officer, who will join the company and board in May. Read More

IN BRIEF: Institut Merieux ups stake in Oxford BioMedica toward 10%

29th Jan 2024 12:35

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy - Completes purchase of ABL Europe SAS from Institut Merieux SA, cementing the partnership between Oxford BioMedica and Institut Merieux. ABL is a cell and gene therapy contract development and manufacturing organization with facilities in Lyon and Strasbourg in France. For the EUR15 million acquisition, Oxford BioMedica will issue 3.1 million new shares to Lyon-based Institut Merieux at a price of 407.4 pence, well above its current market price. This is a 3.2% stake, and Institut Merieux already had 3.3%, giving it a total 6.5% holding. Oxford BioMedica says Institut Merieux intends to raise this to 10.0% by the end of the September. Read More

Oxford BioMedica posts optimistic outlook on uptick in contract value

7th Dec 2023 21:10

(Alliance News) - Oxford BioMedica PLC on Thursday said it is on track to achieve its guidance for the year, amid an uptick in current contracted value and growth supported by new orders. Read More

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

5th Dec 2023 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

Oxford BioMedica buys ABL Europe for consideration of EUR15 million

4th Dec 2023 10:32

(Alliance News) - Oxford BioMedica PLC on Monday said that it has entered a sale and purchase agreement with TSGH SAS for the acquisition of ABL Europe SAS. Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered